Publications by authors named "C J Fritz"

Introduction: Capnocytophaga is a genus of bacteria that are commensal to the oral microbiome of humans and some animals. Some Capnocytophaga species are found in the human oral cavity and rarely cause disease in people; the species found in animals are zoönotic and can be transmitted to people via saliva. This study describes the clinical and epidemiologic features of patients from whom Capnocytophaga spp.

View Article and Find Full Text PDF

When we touch ourselves, the pressure appears weaker compared to when someone else touches us, an effect known as sensory attenuation. Sensory attenuation is spatially tuned and does only occur if the positions of the touching and the touched body-party spatially coincide. Here, we ask about the contribution of visual or proprioceptive signals to determine self-touch.

View Article and Find Full Text PDF

Introduction: Temporomandibular disorder (TMD) is a common, yet potentially debilitating syndrome that negatively impacts patient quality of life. In patients with severe variants of TMD, temporomandibular joint (TMJ) devices have been utilized to replace the joint altogether. However, the risk profile and consequent cost-benefit ratio of these devices is largely debated.

View Article and Find Full Text PDF

Rewetting peatlands is required to limit carbon dioxide (CO) emissions, however, raising the groundwater level (GWL) will strongly increase the chance of methane (CH) emissions which has a higher radiative forcing than CO. Data sets of CH from different rewetting strategies and natural systems are scarce, and quantification and an understanding of the main drivers of CH emissions are needed to make effective peatland rewetting decisions. We present a large data set of CH fluxes (FCH) measured across 16 sites with eddy covariance on Dutch peatlands.

View Article and Find Full Text PDF

Hairy cell leukemia variant (HCL-v) is a rare malignancy of clonal mature B-cells that follows a chronic disease course. HCL-v patients are often resistant to purine nucleoside analogs, which are the first-line therapy. To address the shortcomings of current therapy for HCL-v, we investigated the activity of a BAFF ligand-based CAR-T cell which binds to all three BAFF receptors, BAFF-receptor, TACI, and BCMA.

View Article and Find Full Text PDF